glp 1 drugs and lupus GLP-1 Medications: A New Hope for Patients Can GLP-1's Be Used to

Weintraub M

They are released throughout the day, increasing at mealtimes, and have several functions: Stimulate the production and secretion of insulin in response to eating (glucose-dependent insulin secretion) GLP-1 enhances the sensitivity of alpha cells to glucose, resulting in more glucose-appropriate glucagon secretion Slow digestion and decrease appetite Thus, DPP-4 inhibitors indirectly enhance insulin release, suppress glucagon secretion, and improve glycaemic control

[DOI] [PMC free article] [PubMed] [Google Scholar] 95.Ferdinand KC, White WB, Calhoun DA, Lonn EM, Sager PT, Brunelle R, Jiang HH, Threlkeld RJ, Robertson KE, Geiger MJ

Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications originally developed for managing type 2 diabetes

Roshini Raj, a New York gastroenterologist, said on TODAY

The mechanism is well understood and supported by scientific literature: 1